Assignee
NEW RIVER PHARMACEUTICALS INC
US·9 granted patents·8 pending applications·644 citations·filing 1999–2007
Top patents by PatentIndex Score
17 records- 0197US7105486B2Abuse-resistant amphetamine compoundsNEW RIVER PHARMACEUTICALS INC·Filed 2004·Granted Sep 12, 2006·160 cites·15 claims
- 0296US7223735B2Abuse resistant lysine amphetamine compoundsNEW RIVER PHARMACEUTICALS INC·Filed 2004·Granted May 29, 2007·67 cites·18 claims
- 0396US7060708B2Active agent delivery systems and methods for protecting and administering active agentsNEW RIVER PHARMACEUTICALS INC·Filed 2002·Granted Jun 13, 2006·128 cites·77 claims
- 0493US6716452B1Active agent delivery systems and methods for protecting and administering active agentsNEW RIVER PHARMACEUTICALS INC·Filed 2000·Granted Apr 6, 2004·190 cites·64 claims
- 0590US7169752B2Compounds and compositions for prevention of overdose of oxycodoneNEW RIVER PHARMACEUTICALS INC·Filed 2004·Granted Jan 30, 2007·30 cites·87 claims
- 0687US7338939B2Abuse-resistant hydrocodone compoundsNEW RIVER PHARMACEUTICALS INC·Filed 2004·Granted Mar 4, 2008·21 cites·11 claims
- 0787US7163918B2Iodothyronine compositionsNEW RIVER PHARMACEUTICALS INC·Filed 2002·Granted Jan 16, 2007·33 cites·25 claims
- 0872US7018654B2Pharmaceutical composition containing an active agent in an amino acid copolymer structureNEW RIVER PHARMACEUTICALS INC·Filed 2001·Granted Mar 28, 2006·11 cites·26 claims
- 0959US2008207668A1Pharmaceutical compositions of hydromorphone for prevention of overdose or abuseNEW RIVER PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1059US2004116391A1Stabilized thyroxine compoundsNEW RIVER PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 1158US2004127397A1Active agent delivery systems and methods for protecting and administering active agentsNEW RIVER PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 1256US2007066537A1Compounds and compositions for prevention of overdose of oxycodoneNEW RIVER PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1355US2005065086A1Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levelsNEW RIVER PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1452US2007060500A1Pharmaceutical compositions for prevention of overdose or abuseNEW RIVER PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1544US2007099841A1Prodrugs of T3 and T4 with enhanced bioavailabilityNEW RIVER PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1643US2008260691A1Prodrugs of Ribavirin with Improved Hepatic DeliveryNEW RIVER PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1737US6627660B1Stabilized thyroxine compoundsNEW RIVER PHARMACEUTICALS INC·Filed 1999·Granted Sep 30, 2003·4 cites·108 claims
Join the waitlist — get patent alerts
Get an alert when NEW RIVER PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →